HEADER HYDROLASE 07-DEC-07 3BKL TITLE TESTIS ACE CO-CRYSTAL STRUCTURE WITH KETONE ACE INHIBITOR KAW COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PEPTIDASE M2 2 DOMAIN; COMPND 5 SYNONYM: DIPEPTIDYL CARBOXYPEPTIDASE I,KININASE II,CD143 ANTIGEN; COMPND 6 EC: 3.4.15.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE, DCP, DCP1; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: CHO-K1; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PLEN-TACEDELTA36-G13 KEYWDS ENZYME-INHIBITOR COMPLEX, GEM-DIOL, DOMAIN-SELECTIVE, KEYWDS 2 CARBOXYPEPTIDASE, GLYCOPROTEIN, HYDROLASE, MEMBRANE, METAL-BINDING, KEYWDS 3 METALLOPROTEASE, PHOSPHOPROTEIN, PROTEASE, SECRETED, TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.WATERMEYER,W.L.KROGER,H.G.O'NEILL,B.T.SEWELL,E.D.STURROCK REVDAT 8 20-OCT-21 3BKL 1 SEQADV HETSYN REVDAT 7 29-JUL-20 3BKL 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE ATOM REVDAT 6 25-OCT-17 3BKL 1 REMARK REVDAT 5 13-JUL-11 3BKL 1 VERSN REVDAT 4 31-MAR-10 3BKL 1 TITLE REVDAT 3 24-FEB-09 3BKL 1 VERSN REVDAT 2 23-SEP-08 3BKL 1 AUTHOR REVDAT 1 10-JUN-08 3BKL 0 JRNL AUTH J.M.WATERMEYER,W.L.KROGER,H.G.O'NEILL,B.T.SEWELL, JRNL AUTH 2 E.D.STURROCK JRNL TITL PROBING THE BASIS OF DOMAIN-DEPENDENT INHIBITION USING NOVEL JRNL TITL 2 KETONE INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME JRNL REF BIOCHEMISTRY V. 47 5942 2008 JRNL REFN ISSN 0006-2960 JRNL PMID 18457420 JRNL DOI 10.1021/BI8002605 REMARK 2 REMARK 2 RESOLUTION. 2.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 45974.602 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.8 REMARK 3 NUMBER OF REFLECTIONS : 32926 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1753 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.18 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.32 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4722 REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE : 0.2710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 371 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4749 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 127 REMARK 3 SOLVENT ATOMS : 233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.79000 REMARK 3 B22 (A**2) : -2.90000 REMARK 3 B33 (A**2) : 0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.22 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.170 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.260 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.050 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.950 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 42.56 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : ACT_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 6 : GOL_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 7 : N84.PAR2_JEAN.TXT REMARK 3 PARAMETER FILE 8 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ACT_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 5 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 6 : GOL_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 7 : N84.TOP2_JEAN.TXT REMARK 3 TOPOLOGY FILE 8 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3BKL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000045635. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : SI(111) CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34837 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.180 REMARK 200 RESOLUTION RANGE LOW (A) : 43.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.18 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.42100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR 2.5 REMARK 200 STARTING MODEL: PDB ENTRY 2IUL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE, PEG 4000, ZNSO4, PH REMARK 280 4.7, TEMPERATURE 289K, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.92450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.46000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.51900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.46000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.92450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.51900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 37 REMARK 465 VAL A 38 REMARK 465 THR A 39 REMARK 465 PRO A 297 REMARK 465 SER A 435 REMARK 465 GLU A 436 REMARK 465 SER A 625 REMARK 465 ALA A 626 REMARK 465 ARG A 627 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 239 O HOH A 1041 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 72 79.06 -170.59 REMARK 500 VAL A 104 -74.45 -47.10 REMARK 500 ASN A 105 -19.41 -49.58 REMARK 500 GLU A 123 -132.66 42.77 REMARK 500 ALA A 125 -7.17 -59.88 REMARK 500 GLN A 155 42.38 36.12 REMARK 500 VAL A 291 114.99 -39.58 REMARK 500 ASN A 361 14.73 -142.33 REMARK 500 LYS A 363 -34.61 -135.93 REMARK 500 PRO A 623 -176.88 -62.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 701 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 383 NE2 REMARK 620 2 HIS A 387 NE2 105.8 REMARK 620 3 GLU A 411 OE1 94.8 99.0 REMARK 620 4 KAW A 800 OAE 110.1 136.1 102.3 REMARK 620 5 KAW A 800 OAF 90.3 96.2 162.0 59.8 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1O8A RELATED DB: PDB REMARK 900 RELATED ID: 1O86 RELATED DB: PDB REMARK 900 RELATED ID: 2IUL RELATED DB: PDB REMARK 900 RELATED ID: 1UZE RELATED DB: PDB REMARK 900 RELATED ID: 1UZF RELATED DB: PDB REMARK 900 RELATED ID: 2IUX RELATED DB: PDB REMARK 900 RELATED ID: 3BKK RELATED DB: PDB DBREF 3BKL A 37 627 UNP P12821 ACE_HUMAN 642 1232 SEQADV 3BKL GLY A 64 UNP P12821 GLU 669 ENGINEERED MUTATION SEQADV 3BKL GLN A 90 UNP P12821 ASN 695 ENGINEERED MUTATION SEQADV 3BKL GLN A 155 UNP P12821 ASN 760 ENGINEERED MUTATION SEQADV 3BKL GLN A 337 UNP P12821 ASN 942 ENGINEERED MUTATION SEQADV 3BKL GLN A 586 UNP P12821 ASN 1191 ENGINEERED MUTATION SEQRES 1 A 591 LEU VAL THR ASP GLU ALA GLU ALA SER LYS PHE VAL GLU SEQRES 2 A 591 GLU TYR ASP ARG THR SER GLN VAL VAL TRP ASN GLU TYR SEQRES 3 A 591 ALA GLY ALA ASN TRP ASN TYR ASN THR ASN ILE THR THR SEQRES 4 A 591 GLU THR SER LYS ILE LEU LEU GLN LYS ASN MET GLN ILE SEQRES 5 A 591 ALA GLN HIS THR LEU LYS TYR GLY THR GLN ALA ARG LYS SEQRES 6 A 591 PHE ASP VAL ASN GLN LEU GLN ASN THR THR ILE LYS ARG SEQRES 7 A 591 ILE ILE LYS LYS VAL GLN ASP LEU GLU ARG ALA ALA LEU SEQRES 8 A 591 PRO ALA GLN GLU LEU GLU GLU TYR ASN LYS ILE LEU LEU SEQRES 9 A 591 ASP MET GLU THR THR TYR SER VAL ALA THR VAL CYS HIS SEQRES 10 A 591 PRO GLN GLY SER CYS LEU GLN LEU GLU PRO ASP LEU THR SEQRES 11 A 591 ASN VAL MET ALA THR SER ARG LYS TYR GLU ASP LEU LEU SEQRES 12 A 591 TRP ALA TRP GLU GLY TRP ARG ASP LYS ALA GLY ARG ALA SEQRES 13 A 591 ILE LEU GLN PHE TYR PRO LYS TYR VAL GLU LEU ILE ASN SEQRES 14 A 591 GLN ALA ALA ARG LEU ASN GLY TYR VAL ASP ALA GLY ASP SEQRES 15 A 591 SER TRP ARG SER MET TYR GLU THR PRO SER LEU GLU GLN SEQRES 16 A 591 ASP LEU GLU ARG LEU PHE GLN GLU LEU GLN PRO LEU TYR SEQRES 17 A 591 LEU ASN LEU HIS ALA TYR VAL ARG ARG ALA LEU HIS ARG SEQRES 18 A 591 HIS TYR GLY ALA GLN HIS ILE ASN LEU GLU GLY PRO ILE SEQRES 19 A 591 PRO ALA HIS LEU LEU GLY ASN MET TRP ALA GLN THR TRP SEQRES 20 A 591 SER ASN ILE TYR ASP LEU VAL VAL PRO PHE PRO SER ALA SEQRES 21 A 591 PRO SER MET ASP THR THR GLU ALA MET LEU LYS GLN GLY SEQRES 22 A 591 TRP THR PRO ARG ARG MET PHE LYS GLU ALA ASP ASP PHE SEQRES 23 A 591 PHE THR SER LEU GLY LEU LEU PRO VAL PRO PRO GLU PHE SEQRES 24 A 591 TRP GLN LYS SER MET LEU GLU LYS PRO THR ASP GLY ARG SEQRES 25 A 591 GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR ASN SEQRES 26 A 591 GLY LYS ASP PHE ARG ILE LYS GLN CYS THR THR VAL ASN SEQRES 27 A 591 LEU GLU ASP LEU VAL VAL ALA HIS HIS GLU MET GLY HIS SEQRES 28 A 591 ILE GLN TYR PHE MET GLN TYR LYS ASP LEU PRO VAL ALA SEQRES 29 A 591 LEU ARG GLU GLY ALA ASN PRO GLY PHE HIS GLU ALA ILE SEQRES 30 A 591 GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO LYS HIS SEQRES 31 A 591 LEU HIS SER LEU ASN LEU LEU SER SER GLU GLY GLY SER SEQRES 32 A 591 ASP GLU HIS ASP ILE ASN PHE LEU MET LYS MET ALA LEU SEQRES 33 A 591 ASP LYS ILE ALA PHE ILE PRO PHE SER TYR LEU VAL ASP SEQRES 34 A 591 GLN TRP ARG TRP ARG VAL PHE ASP GLY SER ILE THR LYS SEQRES 35 A 591 GLU ASN TYR ASN GLN GLU TRP TRP SER LEU ARG LEU LYS SEQRES 36 A 591 TYR GLN GLY LEU CYS PRO PRO VAL PRO ARG THR GLN GLY SEQRES 37 A 591 ASP PHE ASP PRO GLY ALA LYS PHE HIS ILE PRO SER SER SEQRES 38 A 591 VAL PRO TYR ILE ARG TYR PHE VAL SER PHE ILE ILE GLN SEQRES 39 A 591 PHE GLN PHE HIS GLU ALA LEU CYS GLN ALA ALA GLY HIS SEQRES 40 A 591 THR GLY PRO LEU HIS LYS CYS ASP ILE TYR GLN SER LYS SEQRES 41 A 591 GLU ALA GLY GLN ARG LEU ALA THR ALA MET LYS LEU GLY SEQRES 42 A 591 PHE SER ARG PRO TRP PRO GLU ALA MET GLN LEU ILE THR SEQRES 43 A 591 GLY GLN PRO GLN MET SER ALA SER ALA MET LEU SER TYR SEQRES 44 A 591 PHE LYS PRO LEU LEU ASP TRP LEU ARG THR GLU ASN GLU SEQRES 45 A 591 LEU HIS GLY GLU LYS LEU GLY TRP PRO GLN TYR ASN TRP SEQRES 46 A 591 THR PRO ASN SER ALA ARG MODRES 3BKL ASN A 72 ASN GLYCOSYLATION SITE MODRES 3BKL ASN A 109 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET FUC B 3 10 HET NAG A 691 14 HET NAG A 902 15 HET ZN A 701 1 HET CL A 702 1 HET CL A 703 1 HET ACT A 705 4 HET ACT A 706 4 HET ACT A 708 4 HET KAW A 800 39 HET GOL A 704 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION HETNAM ACT ACETATE ION HETNAM KAW N-{(5S)-4,4-DIHYDROXY-6-PHENYL-5-[(PHENYLCARBONYL) HETNAM 2 KAW AMINO]HEXANOYL}-L-TRYPTOPHAN HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 2 FUC C6 H12 O5 FORMUL 5 ZN ZN 2+ FORMUL 6 CL 2(CL 1-) FORMUL 8 ACT 3(C2 H3 O2 1-) FORMUL 11 KAW C30 H31 N3 O6 FORMUL 12 GOL C3 H8 O3 FORMUL 13 HOH *233(H2 O) HELIX 1 1 ASP A 40 THR A 71 1 32 HELIX 2 2 THR A 74 ARG A 100 1 27 HELIX 3 3 LYS A 101 PHE A 102 5 2 HELIX 4 4 ASP A 103 LEU A 107 5 5 HELIX 5 5 ASN A 109 GLN A 120 1 12 HELIX 6 6 LEU A 122 LEU A 127 5 6 HELIX 7 7 PRO A 128 ALA A 149 1 22 HELIX 8 8 PRO A 163 SER A 172 1 10 HELIX 9 9 LYS A 174 ALA A 189 1 16 HELIX 10 10 ALA A 189 LEU A 194 1 6 HELIX 11 11 PHE A 196 ASN A 211 1 16 HELIX 12 12 ASP A 215 SER A 222 1 8 HELIX 13 13 MET A 223 GLU A 225 5 3 HELIX 14 14 SER A 228 LEU A 240 1 13 HELIX 15 15 LEU A 240 GLY A 260 1 21 HELIX 16 16 TRP A 283 ASN A 285 5 3 HELIX 17 17 ILE A 286 VAL A 291 1 6 HELIX 18 18 ASP A 300 GLN A 308 1 9 HELIX 19 19 THR A 311 LEU A 326 1 16 HELIX 20 20 PRO A 332 SER A 339 1 8 HELIX 21 21 ASN A 374 TYR A 394 1 21 HELIX 22 22 PRO A 398 ARG A 402 5 5 HELIX 23 23 ASN A 406 THR A 423 1 18 HELIX 24 24 THR A 423 LEU A 430 1 8 HELIX 25 25 SER A 439 ILE A 455 1 17 HELIX 26 26 ALA A 456 ASP A 473 1 18 HELIX 27 27 THR A 477 GLU A 479 5 3 HELIX 28 28 ASN A 480 GLY A 494 1 15 HELIX 29 29 PHE A 506 LYS A 511 5 6 HELIX 30 30 PHE A 512 SER A 517 1 6 HELIX 31 31 TYR A 520 ALA A 541 1 22 HELIX 32 32 PRO A 546 CYS A 550 5 5 HELIX 33 33 SER A 555 LEU A 568 1 14 HELIX 34 34 PRO A 573 GLY A 583 1 11 HELIX 35 35 ALA A 589 HIS A 610 1 22 SHEET 1 A 2 THR A 150 CYS A 152 0 SHEET 2 A 2 CYS A 158 GLN A 160 -1 O LEU A 159 N VAL A 151 SHEET 1 B 2 ILE A 270 PRO A 271 0 SHEET 2 B 2 LEU A 495 CYS A 496 1 O CYS A 496 N ILE A 270 SHEET 1 C 2 SER A 355 ASP A 358 0 SHEET 2 C 2 PHE A 365 LYS A 368 -1 O ARG A 366 N TRP A 357 SSBOND 1 CYS A 152 CYS A 158 1555 1555 2.05 SSBOND 2 CYS A 352 CYS A 370 1555 1555 2.06 SSBOND 3 CYS A 538 CYS A 550 1555 1555 2.05 LINK ND2 ASN A 72 C1 NAG A 691 1555 1555 1.45 LINK ND2 ASN A 109 C1 NAG B 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.37 LINK O6 NAG B 1 C1 FUC B 3 1555 1555 1.40 LINK NE2 HIS A 383 ZN ZN A 701 1555 1555 2.17 LINK NE2 HIS A 387 ZN ZN A 701 1555 1555 2.09 LINK OE1 GLU A 411 ZN ZN A 701 1555 1555 2.10 LINK ZN ZN A 701 OAE KAW A 800 1555 1555 2.23 LINK ZN ZN A 701 OAF KAW A 800 1555 1555 2.42 CISPEP 1 GLU A 162 PRO A 163 0 0.15 CRYST1 59.849 85.038 134.920 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016709 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011759 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007412 0.00000 MASTER 300 0 13 35 6 0 0 6 0 0 0 46 END